Status: Recruiting
Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
This is a single-arm, single-dose dose-escalation and dose-expansion study.
Participants needed: 24
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Guangzhou Bio-gene Technology Co., LtdUpdated: Apr 17, 2025Locations: 3
Eligibility criteria
Voluntarily sign the informed consent and be expected to complete the follow-up... [+18]
Acute promyelocytic leukemia was diagnosed. [+22]